Charles A Rowland Jr Blueprint Medicines Corp (BPMC) insider trading activity

Charles A Rowland Jr is Director of Blueprint Medicines Corp. Currently has a direct ownership of 5,812 shares of BPMC, which is worth approximately $501,575. The most recent transaction as insider was on Jun 02, 2021, when has been sold 2,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.81K

0% 3M change

0% 12M change

Total Value Held $501,575

Charles A Rowland Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 02 2021	BUY Grant, award, or other acquisition	-	2,250 Added 27.91%	5,812 Common Stock
Dec 17 2020	SELL Open market or private sale	$1,285,298 $117.82 p/Share	10,909 Reduced 75.39%	3,562 Common Stock
Dec 17 2020	BUY Exercise of conversion of derivative security	$213,053 $19.53 p/Share	10,909 Added 42.98%	14,471 Common Stock
Nov 03 2020	SELL Open market or private sale	$544,027 $98.52 p/Share	5,522 Reduced 60.79%	3,562 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$52,238 $9.46 p/Share	5,522 Added 37.81%	9,084 Common Stock
Nov 02 2020	SELL Open market or private sale	$443,815 $99.11 p/Share	4,478 Reduced 55.7%	3,562 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$42,362 $9.46 p/Share	4,478 Added 35.77%	8,040 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

VKTX

Viking Therapeutics, Inc. Healthcare

Director

ORTX

Orchard Therapeutics plc Healthcare

NBRV

Nabriva Therapeutics plc Healthcare

Director

CAR